Longeveron Inc. SEC filings LGVN
Longeveron Inc. has 530 filings in SEC EDGAR's recent list, going back to Nov 6, 2017. Its latest annual report, Form ARS, was filed on May 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 20, 2026 | — |
| DEF 14A | Proxy statement | May 20, 2026 | Jul 1, 2026 |
| PRE 14A | Preliminary proxy statement | May 5, 2026 | May 5, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 3, 2026 | Mar 3, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 13, 2025 |
| DEFA14A | Additional proxy material | May 20, 2024 | — |
| DEF 14A | Proxy statement | May 20, 2024 | Jul 2, 2024 |
| DEF 14A | Proxy statement | Feb 5, 2024 | Feb 21, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 25, 2024 | Jan 25, 2024 |
| DEFA14A | Additional proxy material | Nov 14, 2023 | — |
| DEF 14A | Proxy statement | Nov 14, 2023 | Dec 26, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 2, 2023 | Nov 2, 2023 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 9, 2023 |
| DEFA14A | Additional proxy material | May 13, 2022 | — |
| DEF 14A | Proxy statement | May 13, 2022 | Jun 24, 2022 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LGVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1721484
- Former names
- LONGEVERON LLC (until Feb 10, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.